PMO Antibiotic Efficacy in Mammalian Cells Georgi Mitev Dept. of Biochem/Biophys Mentor: Dr. Bruce Geller Department of Microbiology AVI Biopharma, Inc.

Slides:



Advertisements
Similar presentations
Chapter 20: Antimicrobial Drugs
Advertisements

Control of Microbial Growth Tim Ho University of Alberta, Canada * The materials are mostly based on Dr. Brian Lanoil’s Microb Part.
Preparing an Overnight Culture of Escherichia coli
The Search for Hypermutability: Determining Frequency of Mutation in Mycobacterium smegmatis mc2155 ___________ Susan Puckett Mentors: Dr. Digby Warner,
Peter Kirby Dept. of Microbiology Resistance to Peptide - Phosphorodiamidate Morpholino Oligomers in E. Coli Mentor: Bruce Geller Dept. of Microbiology.
PRESENTED BY: LAUREN SHIN MENTOR: DR. LUIZ BERMUDEZ MICROBIOLOGY DEPARTMENT Determining the Role of the luxR homolog in Mycobacterium avium subsp. paratuberculosis.
Sasha Rose Mentor: Dr. Luiz Bermudez OSU College of Veterinary Medicine Department of Biomedical Sciences Using In Vivo Expression Technology to Identify.
Chlamydial inclusion membrane proteins: localization and characterization Nathanael Blake HHMI Summer Internship Mentor: Dr. Dan Rockey.
Genetic Analysis of Mycobacterial Susceptibility to Antimicrobial Peptides Nima Motamedi Dr. Luiz Bermudez.
Transformation of Escherichia coli
Kate Bateman Mentors: Dr. Dennis Hruby …… Tove’ Bolken Department of Microbiology.
HHMI at AVI BioPharma PMOs as Antibiotics: Gene-specific Inhibition of E. coli Mentor: Dr. Bruce Geller Susan Puckett.
Identifying Genes in E. coli Required for Susceptibility to Antisense Antibiotics Susan Puckett Mentor: Dr. Bruce Geller AVI BioPharma Howard Hughes Medical.
Chemical Agents that Affect Microbial Growth.  A chemical substance used in treatment of infectious disease. ◦ Bacteriocidal agents.  Kill bacterial.
Antibiotics Biotechnology II. Univ S. Carolina Antibiotics Disrupt Cell Wall Synthesis, Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
Group 6 GERMS, DRUGS and GENES: Revealing mechanisms of gene expression using antibiotics Alejandro Calderon-Urrea Nancy Connell Nigel Crawford Mamta Rawat.
7.1 Techniques for Producing and Analyzing DNA SBI4UP MRS. FRANKLIN.
Environmental Factors that Influence Microbes Including Antimicrobial Agents.
Biotechnology: Bacterial Transformation Lab
Control of microbial growth. Antimicrobial Classes Disinfectants –Products aimed at reducing by at least five powers of 10 (99,999 %) the number of microorganisms/virus.
Generation of Transcription Factor Constructs for Mammalian Transfection Leah Schumerth, Michael Farrell, and Winnifred Bryant Ph. D. Department of Biology.
Chapter 9 – DNA-Based Information Technologies
Manufacture of Human Interleukin 13 Protein Using a Prokaryotic Expression System Ryan Rupp, York College of Pennsylvania, Department of Biological Sciences.
Cloning and rDNA (II) Dr. Abdulaziz Almalik
Learning Targets “I Can...” -Explain what it means for a gene to be expressed. -Explain the role of plasmids. -Define bacteria “transformation.” -Insert.
ANTIBIOTIC SUSCEPTIBILITY TESTING AND DRUG RESISTANCE Rashmi S.
Antimicrobial Drugs Chemotherapy: Use of chemicals that do not harm the host yet kills others. Chemotherapeutic agent: substance that is used in medicine.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Batterjee Medical College. Dr. Manal El Said Department Head of Microbiology Antimicrobial Drugs: Mechanism of Action.
Antibiotic Resistance in Microbes A few microbes to be concerned about How some antibiotics and Antimicrobials work Resistance mechanisms Some factors.
Antimicrobial Drugs.
Classification of a Novel Marine Bacterial Species: HTCC 2207
Transcription Analysis of Tetracylcine Resistant Genes in Chlamydia suis Presented by Erika K. VanDenBerg Mentor Dr. Dan Rockey Department of Microbiology.
Department of Microbiology & Immunology
Changes in Gene Expression Induced by RNA Polymerase Inhibitors in Shigella flexneri Department of Biology Loyola Marymount University November 24, 2015.
Antisense Phosphorodiamidate Morpholino Oligomer-Peptide Conjugate: Dose-Response in Mice Infected with Escherichia coli Lucas Tilley 1, Patrick Iversen.
Antimicrobial Drugs  Chemotherapy: the use of drugs to treat a disease  Antimicrobial drugs: interfere with the growth of microbes within a host  Antibiotic:
Growth Kinetics of Parent and Green Fluorescent Protein-Producing Strains of Salmonella Thomas P. Oscar, Agricultural Research Service, USDA, 1124 Trigg.
Plasmids and Vectors Aims:
Bacterial Plasmids Loops of DNA found in some bacteria
Liquid cultures to Lysis: Movie Clip from Teachers domain Student Guide Lab 6.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Antimycobacterial Drugs September Mycobacteria Mycobacteria are intrinsically resistant to most antibiotics. Because they grow slowly compared with.
Transformation of Escherichia coli
Chapter 42 Antimicrobial Sensitivity Testing
Accelerated Biology Transformation Lab
Targeting Multidrug-resistant Staphylococci with an anti-rpoA Peptide Nucleic Acid Conjugated to the HIV-1 TAT Cell Penetrating Peptide  Mostafa FN Abushahba,
Pharmacodynamics of novel Mycobacteria tuberculosis DNA gyrase inhibitors EMMANUEL MOYO.
ANTIBIOTIC SENSITIVITY
Regulation of gene and cellular activity
محاضرة عامة التقنيات الحيوية (هندسة الجينات .. مبادئ وتطبيقات)
Accelerated Biology Transformation Lab
Lab# 2 Competent Cells Formation and Transformation of Competent Cells with plasmid DNA. BCH 462 [practical]
Targeted Nanoparticles Deliver siRNA to Melanoma
Chemotherapeutic agent
Genetic Engineering First, the nucleus of human cells are burst
ANTIBIOTIC RESISTANCE
Tools of the Laboratory Power Point #1: Culturing Microorganisms
ANTIMICROBIALS Chapter 10.
Transformation of Escherichia coli
Genetic Engineering First, the nucleus of human cells are burst
Enzyme Regulation 1.
Volume 10, Issue 5, Pages (November 2011)
A Major Role for Capsule-Independent Phagocytosis-Inhibitory Mechanisms in Mammalian Infection by Cryptococcus neoformans  Cheryl D. Chun, Jessica C.S.
Volume 15, Issue 8, Pages (August 2007)
Targeting Antibiotic Tolerance, Pathogen by Pathogen
Transformation of Escherichia coli
Transformation of Escherichia coli
Transformation of Escherichia coli
“Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1” Ihtisham Ul Haq Roll No: 13 Subject: Seminar.
Presentation transcript:

PMO Antibiotic Efficacy in Mammalian Cells Georgi Mitev Dept. of Biochem/Biophys Mentor: Dr. Bruce Geller Department of Microbiology AVI Biopharma, Inc.

Antibiotics Today  Antibiotics becoming less effective  Novel antibiotics needed  Example: Mycobacterium tuberculosis in America  % of Multi Drug Resistant cases are Extremely Drug Resistant  increased to 4.5%

Phosphorodiamidate Morpholino Oligomers  10 bases  Phophorodiamidate linkages  Not a substrate for nucleases

PMO and DNA

PMOs and gene expression  PMOs are selectively reactive  PMOs bond to RNA

Gene Expression

Introducing PMO  DNA is transcribed into RNA  RNA binds to complementary PMO  Translation is blocked  PMO specificity

AVI Research  PMO pure culture E. coli and S. typhimurium  PMO targeted to AcpP gene

E. coli pure culture growth with PMO treatments

S. typhimurium pure culture growth with PMO treatments

AVI Research  Must also inhibit in tissue culture

E. coli tissue culture growth with PMO treatments

My Project  E. coli grows extracellularly  Can the PMO also work on an intracellular pathogen, such as S. typhimurium, growing in mammalian cells?  PMO must penetrate both human cell and bacterial cell  Similar PMO targeted to intracellular Mycobacterium tuberculosis inhibited growth in tissue culture  Research could lead to therapeutics for other intracellular pathogens such as Chlamydia trachomatis or Neisseria gonorrhea

Hypothesis  PMOs targeted to the AcpP gene in S. typhimurium will be able to inhibit growth intracellularly in tissue culture

Research  Find suitable drug for new strain S. typhimurium 14028s  AcpP neutral PMO  AcpP 3+ PMO  Both are 11 bases long and targeted to start codon

Minimal Inhibitory Concentration 1  MIC for targeted neutral PMO μM  MIC for targeted 3+ PMO μM  Ampicillin has a MIC of about 30 μM

Growth Curve 1  Comparison of 2x MIC concentration of targeted neutral PMO and targeted 3+ PMO  Measured by optical density and viable cell count

Growth Curve 1

Growth Curve 2  Comparison of drugs at same concentration

Growth Curve 2

Tissue culture 1  Test Targeted 3+ PMO efficacy in mouse macrophage cells  S. typhmurium inoculation  Extracellularly sterilized with gentomycin 10 mg/mL  Treated at 0 h with 3.13  M 3+ PMO  Lysed and plated

Tissue Culture 1

Tissue Culture 2  Test for ratio of bacterial cell to culture cells  Carry experiment out to 42 h  Test for gentomycin efficacy  Treated at each time point

Tissue Culture 2

Further Research  Test M. avium  What is the most effective target site for the PMO? Stem vs. loop

Acknowledgements  Funding  HHMI  AVI Biopharma  Dr. Bruce Geller  Shannon Oda  Brett Mellbye  Susan Puckett  Dr. Pat Iversen  Dr. Kevin Ahern